Drugs / Ingenol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01703078 | Nov 2012 → Mar 2013 | actinic keratosis | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ingenol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01703078 ↗ |
| Modality | Small molecule | — CHEMBL2165402 ↗ |
| Route | Topical | “Topical Administration” NCT01703078 ↗ |